RLX Technology Inc. Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

Net Revenues: RMB 1.01 billion, a 14.8% year-over-year increase from RMB 880 million.

Gross Profit: RMB 367.8 million, up 47.8% year-over-year.

Gross Margin: Expanded to 35.4%, a 790 basis point increase year-over-year.

Non-GAAP Operating Profit: RMB 149.6 million, up 28.8% year-over-year.

Non-GAAP Net Income: RMB 238.8 million.

Cash Position: Total capital resources stood at RMB 13.9 billion as of June 30, 2026.

2Strategic Updates and Business Highlights

International Growth: International revenues accounted for approximately 70% of total revenues, driven by organic growth and contributions from acquisitions.

Acquisition Strategy: A controlling investment was made in a Western European distribution platform, expected to enhance operational synergies and expand market presence.

Product Diversification: Expansion into multi-category smoke-free products, including modern oral nicotine pouches and heat-not-burn products, with a manufacturing hub under construction in Southeast Asia.

Regulatory Compliance: The company is adapting to stricter regulations in various markets, positioning itself as a compliant leader to eliminate low-quality competition.

3Forward Guidance and Outlook

Second Half Expectations: Anticipated strong overseas performance driven by the consolidation of the European distribution platform and disciplined inventory management.

Margin Outlook: Gross margins expected to normalize but remain healthy, with operational cost controls in place.

Long-term Strategy: Focus on sustainable, profitable growth through disciplined capital allocation, prioritizing high ROI initiatives and strategic M&A.

4Challenges and Points of Concern

Regulatory Environment: Increasing scrutiny and regulatory changes in international markets, particularly in the U.S. and China, could impact growth strategies.

Market Competition: Growing competition in Europe, particularly from established players like Philip Morris, necessitates strong execution and innovation to maintain market share.

Domestic Market Risks: Stricter regulations in China may lead to flat sales year-over-year, impacting short-term growth.

5Notable Q&A Insights

Capital Allocation Strategy: Focus on organic growth, high ROI initiatives, selective M&A, and potential shareholder returns through repurchases and dividends.

U.S. Market Strategy: Cautious approach due to regulatory uncertainties; awaiting clarity before significant capital investment.

European Competition: RLX's unique position as a non-cigarette business and strong supply chain capabilities are seen as competitive advantages.

Oral Nicotine Pouches: Expected to be a key growth driver, with production capabilities being enhanced to meet demand. Overall, RLX Technology reported solid financial results in Q2 2026, with a focus on strategic growth through acquisitions and product diversification while navigating regulatory challenges and competitive pressures.